Ratings by Craig-Hallum (Adam Vogel)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/11/2026 | Alterity Therapeutics | ATHE | New Coverage | Buy (N/A) |
83.33 (4.55) |
-94.54% | Details | |
| 6/23/2026 | MapLight Therapeutics | MPLT | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2026 | Apogee Therapeutics Inc | APGE | Downgrade | Hold (Buy) |
90.38 (135.08) |
49.46% | Details | |
| 6/16/2026 | PepGen Inc. | PEPG | New Coverage | Buy (N/A) |
1.53 (3.12) |
103.92% | Details | |
| 5/21/2026 | MapLight Therapeutics | MPLT | New Coverage | Buy (N/A) |
27.81 (13.31) |
-52.14% | Details | |
| 4/10/2026 | LB Pharmaceuticals Inc | LBRX | New Coverage | Buy (N/A) |
26.29 (47.10) |
79.16% | Details | |
| 3/4/2026 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 1/30/2026 | Aclaris Therapeutis | ACRS | New Coverage | Buy (N/A) |
3.43 (6.02) |
75.51% | Details | |
| 1/7/2026 | Apogee Therapeutics Inc | APGE | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Immunome Inc. | IMNM | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | Design Therapeutics Inc | DSGN | New Coverage | Buy (N/A) |
8.94 (15.14) |
69.35% | Details | |
| 11/3/2025 | Apogee Therapeutics Inc | APGE | New Coverage | Buy (N/A) |
56.59 (135.08) |
138.7% | Details | |
| 9/5/2025 | Immunome Inc. | IMNM | New Coverage | Buy (N/A) |
9.80 (27.07) |
176.22% | Details |
